
|Videos|May 13, 2016
Direct-Acting Antiviral's Impact on Patients' Adherence to HCV Drug Regimen
Author(s)Contagion Editorial Staff
Charitha Gowda, MD, MPH, infectious diseases physician at Penn Presbyterian Medical Center discusses the impact direct-acting antivirals have had on patients’ adherence to their drug regimen when treating hepatitis C.
Advertisement
Charitha Gowda, MD, MPH, infectious diseases physician at Penn Presbyterian Medical Center discusses the impact direct-acting antivirals have had on patients’ adherence to their drug regimen when treating hepatitis C.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contagion Live
1
Top Infectious Disease News Stories Week of November 29 - December 5
2
Early 2025 Influenza Vaccination Trends Following Prior Season and H3N2 Start
3
ACIP Votes on Hepatitis B Vaccine Marks More Confusion, No Supportive Safety Data, and Uncertainty of Public Health Policy
4
Petition Urges EPA to Halt Antibiotic and Antifungal Pesticide Use Over Resistance Risks
5

















































































































































































































































































